Back
Biomarin Pharmaceutical Stock Predictions
Sponsored
BMRN
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Buy
52
BMRN
Biomarin Pharmaceutical
Last Price:
$61.53
Seasonality Move:
-2.99%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]Biomarin Pharmaceutical Stock Forecast
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.1% based on the past 25 years of stock performance.
-
Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?The current Biomarin Pharmaceutical [BMRN] share price is $61.53. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.1% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Buy
52
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical overpriced?
-
Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
94.85
52-Week Low:
60.63
Prediction Charts
Market Cap:
11.7B
Price in USD:
61.53
Volume:
2.6M
Beta:
0.87
Technical Analysis
SMA50:
65.49
SMA100:
70.26
SMA200:
77.22
52-Wk Change:
-34.14%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?Yes, Biomarin Pharmaceutical is a publicly traded company.
-
What is the Biomarin Pharmaceutical stock quote today?The Biomarin Pharmaceutical stock price is 61.53 USD today.
-
How to buy Biomarin Pharmaceutical stock online?You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-27 | 66.89 | 66.89 | 67.47 | 66.38 |
Dec-30 | 66.30 | 65.45 | 66.46 | 65.24 |
Dec-31 | 65.74 | 65.73 | 66.16 | 65.33 |
Jan-2 | 65.97 | 66.49 | 66.74 | 65.86 |
Jan-3 | 66.56 | 66.83 | 67.50 | 66.44 |
Jan-6 | 66.93 | 67.07 | 67.75 | 66.70 |
Jan-7 | 67.07 | 67.90 | 68.85 | 66.91 |
Jan-8 | 67.90 | 68.38 | 69.70 | 67.43 |
Jan-10 | 67.26 | 67.38 | 67.94 | 66.01 |
Jan-13 | 67.58 | 66.99 | 67.58 | 65.95 |
Jan-14 | 67.35 | 63.81 | 67.38 | 63.58 |
Jan-15 | 64.04 | 61.58 | 64.72 | 61.38 |
Jan-16 | 61.85 | 61.25 | 61.85 | 60.63 |
Jan-17 | 61.67 | 61.53 | 62.37 | 61.37 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.